Creo Medical Group PLC Total Liabilities
Creo Medical Group PLC total liabilities. Based on the latest financial reports, Creo Medical Group PLC (CREO) has total liabilities worth GBX9.10 Million GBX (≈ $1.11K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Creo Medical Group PLC liquidity resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Creo Medical Group PLC (2005–2025)
Total liabilities of Creo Medical Group PLC from 2005 to 2025. This chart illustrates how Creo Medical Group PLC's total liabilities have evolved over time, based on quarterly financial data. Explore CREO long-term asset investment ratio to see how much of total assets are deployed in long-term investments.
Creo Medical Group PLC Competitors by Total Liabilities
The table below lists competitors of Creo Medical Group PLC ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kovo Healthtech Corp
V:KOVO
|
Canada | CA$26.79 Million |
|
Oriental Rise Holdings Limited Ordinary Shares
NASDAQ:ORIS
|
USA | $2.78 Million |
|
Prostatype Genomics AB
ST:PROGEN
|
Sweden | Skr7.36 Million |
|
Newtopia Inc
V:NEWU
|
Canada | CA$13.62 Million |
|
Cora Gold Limited
LSE:CORA
|
UK | GBX282.00K |
|
COPPERCORP RESOURCES INC.
F:NU0
|
Germany | €389.97K |
Liability Composition Analysis (2005–2025)
This chart breaks down Creo Medical Group PLC's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Creo Medical Group PLC asset portfolio.
Liquidity & Leverage Metrics
Creo Medical Group PLC Total Liabilities Ratios Explained
Creo Medical Group PLC total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.22 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.18 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.15 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Creo Medical Group PLC's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Creo Medical Group PLC (2005–2025)
The table below shows the annual total liabilities of Creo Medical Group PLC from 2005 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | GBX9.10 Million ≈ $1.11K |
-59.73% |
| 2024-12-31 | GBX22.60 Million ≈ $2.75K |
+34.52% |
| 2023-12-31 | GBX16.80 Million ≈ $2.04K |
-35.22% |
| 2022-12-31 | GBX25.93 Million ≈ $3.16K |
-4.97% |
| 2021-12-31 | GBX27.29 Million ≈ $3.32K |
-7.98% |
| 2020-12-31 | GBX29.66 Million ≈ $3.61K |
+429.58% |
| 2019-12-31 | GBX5.60 Million ≈ $681.39 |
+175.45% |
| 2018-12-31 | GBX2.03 Million ≈ $247.37 |
-11.22% |
| 2018-06-30 | GBX2.29 Million ≈ $278.63 |
+55.67% |
| 2017-06-30 | GBX1.47 Million ≈ $178.99 |
+86.50% |
| 2016-06-30 | GBX788.81K ≈ $95.98 |
+48.05% |
| 2016-02-29 | GBX532.79K ≈ $64.83 |
+80.01% |
| 2015-02-28 | GBX295.98K ≈ $36.01 |
+18.30% |
| 2014-02-28 | GBX250.20K ≈ $30.44 |
+331.38% |
| 2008-02-29 | GBX58.00K ≈ $7.06 |
-76.33% |
| 2007-02-28 | GBX245.00K ≈ $29.81 |
+49.39% |
| 2006-02-28 | GBX164.00K ≈ $19.95 |
+864.71% |
| 2005-02-28 | GBX17.00K ≈ $2.07 |
-- |
About Creo Medical Group PLC
Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develops CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices del… Read more